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ABSTRACT 
 
In the previous studies, the cytotoxicities of anthranilate sulfonamides were investigated. 
Herein, the bioactivities of 4-substituted (X = NO2, OCH3, CH3, Cl) benzenesulfonamides of 
anthranilic acid (5-8) are reported. The results revealed that all sulfonamides selectively ex-
erted antifungal activity (25-50 % inhibition) against C. albicans at 4 µg/mL. Furthermore, 
compounds 6 and 8 show antioxidative (SOD) activity. These sulfonamides, except for 6, se-
lectively display cytotoxic effects toward MOLT-3 cells. It is interesting to note that sulfona-
mides with electron withdrawing substituent (5, X = NO2) exhibited the highest cytotoxicity. 
This study provided preliminary structure-activity relationship of the anthranilic sulfonamides 
that is useful for further in-depth investigation. 
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INTRODUCTION 
Sulfonamides (1, R = heterocyclic 
rings, Figure 1) are compounds constitut-
ing diverse medicinal applications, widely 
used as antimicrobial (Genç et al., 2008; 
Ozbek et al., 2007), anticancer (Ghorab et 
al., 2009; El-Sayed et al., 2011), antiin-
flammatory (Borne et al., 1974) and antivi-
ral agents as well as HIV protease inhibi-
tors (De Clercq, 2001). Sulfonamide (1, R 
=H) is well recognized as an antimetabolite 
(Mengelers et al., 1997). It has a similar 
structure to p-aminobenzoic acid (PABA, 
2) which is an essential compound for the 
synthesis of tetrahydrofolate in bacteria 
(Mengelers et al., 1997). Anthranilic acid 
(o-aminobenzoic acid, 3), an isomeric form 
of PABA, has been shown to be an inter-
esting pharmacophore essential for bio-
logical activities. Its derivatives such as 
anthranilate sulfonamides have been re-
cently reported to be cytotoxic (Shahlaei et 
al., 2010) acting as methionine aminopep-
tidase-2 (MetAP-2) inhibitors. Previously, 
anthranilate-hydroxamic acid sulfonamides 
were reported to act as matrix metallopro-
teinase (MMP) inhibitors. These com-
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pounds were potent inhibitors of MMP-9 
and MMP-13 (Levin et al., 2001). MMP-9 
was shown to be potential inhibitors of tu-
mor metastasis, while MMP-3 provided 
protection against the cartilage degradation 
associated with osteoarthritis.  
Considering the molecular structures of 
anthranilates, the MMP and MetAP-2 in-
hibitors, therefore, simple and small mole-
cules of sulfonamide derivatives of an-
thranilic acid 5-8 (Figure 2) are interesting 
compounds for this investigation. Based on 
the literature, some bioactivities of these 
sulfonamides (5-8), namely antiinflamma-
tory and aldose reductase inhibitory activi-
ties have been previously reported (Borne 
et al., 1974; DeRuiter et al., 1989; Wydysh 
et al., 2009). The present study reports an-
timicrobial, antioxidative and cytotoxic 
effects of the sulfonamides 5-8. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Chemical structures of sulfonamides 
and aminobenzoic acids 
 
In general, sulfonamides are prepared 
from the reaction of amines and sulfonyl 
halides in organic solvents. In this study, 
an environmentally friendly method using 
water as the solvent, was conducted for the 
synthesis of sulfonamides (Figure 2). 
 
 
 
 
 
 
 
 
 
Figure 2: Chemical structures of sulfonamides 
5-8 
MATERIALS AND METHODS 
General 
1H-NMR spectra were recorded on a 
Bruker AVANCE 300 NMR spectrometer 
(operating at 300 MHz for 1H). Infrared 
spectra (IR) were obtained on a Perkin 
Elmer System 2000 FTIR. Melting points 
were determined on an Electrothermal 
melting point apparatus (Electrothermal 
9100) and are uncorrected. Column chro-
matography was carried out using silica gel 
60 (0.063–0.200 mm). Analytical thin 
layer chromatography (TLC) was per-
formed on silica gel 60 PF254 aluminium 
sheets (cat. No. 7747 E., Merck). Solvents 
were distilled prior to use. Reagents for 
cell culture were as follows: RPMI-1640 
(Rosewell Park Memorial Institute me-
dium, Gibco and Hyclone laboratories, 
USA), HEPES (N-2-hydroxyethyl-pipe-
razine-N′-2-ethanesulfonic acid), L-
glutamine, penicillin, streptomycin, so-
dium pyruvate and glucose (Sigma, USA), 
Ham’s/F12 (Nutrient mixture F-12), 
DMEM (Dulbecco’s Modified Eagle’s 
Medium) and FBS (fetal bovine serum, 
Hyclone laboratories, USA), gentamicin 
sulfate (Government Pharmaceutical Or-
ganization, Thailand), MTT (3(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide, Sigma Aldrich, USA). 
Vitamin E, 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) and bovine erythrocyte superoxide 
dismutase (SOD) were obtained from 
Sigma Chemical Co. (USA). DMSO was 
purchased from Fluka. 
 
Tested sulfonamides 
Sulfonamides (5-8) were prepared us-
ing the modified method (Kamal et al., 
2008). A general procedure for the sulfon-
ylation of amine (3) by benzenesulfonyl 
chlorides (4, X = NO2, OCH3, CH3, Cl) is 
as follow. 
A mixture of anthranilic acid (3, 
10 mmol) and substituted arenesulfonyl 
chloride (4, 30 mmol) was suspended in 
water (20 mL). The suspension was basi-
fied (pH 8) with saturated Na2CO3 and fur-
ther stirred at room temperature. The reac-
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tion was monitored by TLC chroma-
tograms. The completed reaction was 
added conc. HCl, precipitates were col-
lected by filtration and washed with 0.1 M 
HCl and cold water. Purification by silica 
gel column chromatography (hex-
ane:EtOAc; 9:1-6:4) gave the desired sul-
fonamides 5-8. Their IR and 1H-NMR 
spectral data and melting points were per-
formed. The compounds are listed as fol-
low. 
2-(4′-Nitrophenylsulfonamido)benzoic 
acid (5); pale-yellow powder (95.70 %), 
m.p. 209-212 °C (lit. m.p. 215-218 °C; 
Borne et al., 1974). 
2-(4′-Methoxyphenylsulfonamido) 
benzoic acid (6); pale-yellow powder 
(98.07 %), m.p. 171-173 °C. 
2-(4′-Methylphenylsulfonamido) 
benzoic acid (7); pale-yellow powder 
(95.86 %), m.p. 186-188 °C (lit. m.p. 229-
231 °C; Borne et al., 1974; lit. m.p. 
212 °C; Peifer et al., 2007). 
2-(4′-Chlorophenylsulfonamido) 
benzoic acid (8); pale-yellow powder 
(80.49 %), m.p. 177-180 °C (lit. m.p. 201-
203 °C; Borne et al., 1974).  
 
Bioactivities 
Antimicrobial assay 
Antimicrobial activity was performed 
using the agar dilution method as previ-
ously described (Prachayasittikul et al., 
2011). The compounds dissolved in 
DMSO were individually mixed with 
Müller Hinton (MH) broth. The solution 
was then transferred to the MH agar solu-
tion to yield the final concentrations of 
256-2 µg/mL. Twenty one strains of mi-
croorganisms, cultured in MH broth at 
37 °C for 24 h, were diluted with 0.9 % 
normal saline solution to adjust the cell 
density of 1×108 cell/mL. The organisms 
were inoculated onto each plate and further 
incubated at 37 °C for 24-48 h. Com-
pounds which possessed high efficacy to 
inhibit bacterial cell growth were analyzed. 
The microorganisms used for the activity 
testing are shown in Table 1. 
Radical scavenging: DPPH assay 
Reaction between DPPH and tested 
compounds was investigated via spectro-
photometric method (Prachayasittikul et 
al., 2010a). The DPPH assay was initiated 
by adding 1 mL of 0.1 mM solution of 
DPPH in methanol to a sample solution 
(0.45 mL, 1 mg/mL dissolved in DMSO). 
The reaction mixture was incubated for 
30 min in a dark room. The absorbance at 
517 nm (UV-1610, Shimadzu) was meas-
ured and the percentage of radical scaveng-
ing activity (RSA) was calculated from the 
following equation:  
 
RSA (%) 100
.
.
1 ×⎟⎟⎠
⎞
⎜⎜⎝
⎛ −=
control
sample
Abs
Abs
 
where controlAbs.  is the absorbance of con-
trol without compounds and sampleAbs.  is 
the absorbance of tested compounds. Vi-
tamin E was used as a standard. 
 
Superoxide scavenging: SOD assay 
Inhibition of the photoreduction of ni-
tro blue tetrazolium (NBT) was performed 
to measure the SOD activity (Suksricha-
valit et al., 2009) The photochemically ex-
cited riboflavin was first reduced by me-
thionine into a semiquinone, which do-
nated an electron to oxygen to form a su-
peroxide source. The superoxide readily 
converted the NBT into a purple formazan 
product. As a result, the SOD activity was 
inversely related to the amount of forma-
zan formation. Purified SOD from bovine 
erythrocytes was used as a control. 
 
Cytotoxic assay 
Cytotoxic assay was evaluated as de-
scribed (Tengchaisri et al., 1998). Cancer 
cells were grown in Ham’s/F12 medium 
containing 2 mM L-glutamine supple-
mented with 100 U/mL penicillin, strepto-
mycin and 10 % FBS, except for HepG2 
cell which was grown in DMEM. Briefly, 
cell lines suspended in RPMI-1640 con-
taining 10 % FBS were seeded with 1×104 
cells (100 µL) per well in a 96-well plate. 
The incubation was performed at 37 °C 
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under humidified atmosphere (95 % air, 
5 % CO2) for 24 h. Additional medium 
(100 µL) containing the test compound and 
vehicle was added to a final concentration 
of 50 µg/mL, 0.2 % DMSO and further 
incubated for 3 days. Cells were fixed with 
95 % EtOH, stained with crystal violet so-
lution and lysed with a solution of 0.1 N 
HCl in MeOH. The absorbance was meas-
ured at 550 nm. On the other hand, 
HuCCA-1, A549 and HepG2 cells were 
stained with MTT. IC50 values were de-
termined as the drug and sample concen-
trations at 50 % inhibition of the cell 
growth. The tested cell lines were T-
lymphoblast (MOLT-3, acute lymphoblas-
tic leukemia), human hepatocellular carci-
noma cell line (HepG2), human cholangio-
carcinoma cancer cell (HuCCA-1) and 
human lung carcinoma cell line (A549). 
 
RESULTS AND DISCUSSION 
Chemistry 
Sulfonamides 5-8 were successfully 
prepared in high yields (80-98 %) using 
the base catalyzed sulfonylation reaction of 
anthranilic acid with 4-substituted ben-
zenesulfonyl chlorides (4) under the modi-
fied environmentally friendly method 
(Kamal et al., 2008). Their structures were 
confirmed by 1H-NMR and IR spectra. Al-
though, the synthesis of sulfonamides 5-8 
were previously reported (Borne et al., 
1974; Wydysh et al., 2009; Deng and 
Mani, 2006), in this study relatively higher 
yield products were achieved. 
 
Biological activities 
Antimicrobial activity 
Compounds 5-8 were tested for their 
antimicrobial action using the agar dilution 
method against twenty-one strains of mi-
croorganisms (gram-positive and gram-
negative bacteria and diploid fungus). It 
was found (Table 1) that the tested com-
pounds selectively displayed growth inhi-
bition (25-50 %) against C. albicans 
ATCC 90028 at 4 µg/mL. When tested at 
higher concentration (128 µg/mL), the sul-
fonamide 5 exhibited 50 % inhibition 
against the C. albicans. The tested sul-
fonamides were found to be inactive anti-
bacterials. 
It was reported that the degree of ioni-
zation of sulfonamido group (-SO2NH-
C6H4-Y) which gave anionic N-atom 
                         , was important for antibac-
terial activity (Genç et al., 2008; Men-
gelers et al., 1997). The anionic form en-
hanced its solubility and caused ionic in-
teraction with receptors e. g. dihydrop-
teroate synthetase or dihydrofolate syn-
thetases (Mengelers et al., 1997). In this 
respect the sulfonamide requires an elec-
tron withdrawing substitutent (Y) on the 
phenyl ring, particularly where Y = NO2 at 
p-position provided the compound with 
high antibacterial activity as compared to 
the m-position (Genç et al., 2008). On the 
other hand, the hydrophobic effect was not 
important for the activity (Mengelers et al., 
1997). The sulfonamides 5-8 were shown 
to be inactive antibacterials, which could 
be due to their sulfonamido moieties                       
(-SO2NH-C6H4-CO2H-ortho) that requires 
the electron withdrawing group at the 
p-position of the phenyl ring (C6H4-
CO2H). 
 
Antioxidative activities 
Studies were performed to investigate 
the superoxide scavenging (SOD) and 
radical scavenging (DPPH) activities of the 
sulfonamides. Compounds 6 and 8 (Table 
2) exhibited weak SOD activity with 15.7 
and 6.1 % NBT inhibition at 300 µg/mL. 
Whereas sulfonamides 5 and 7 were inac-
tive superoxide scavengers. On the other 
hand, all compounds showed no radical 
scavenging activity (DPPH). So far, anti-
oxidant properties of these anthranilic sul-
fonamides were not found in the literature. 
Study of the molecular structures revealed 
that the SOD activity depended on the 
asymmetric charge localization of the 
compound, where high asymmetric charge 
afforded the compound with high SOD ac-
tivity (Prachayasittikul et al., 2010b).  
(-SO2N-C6H4-Y)
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Table 1: Antimicrobial activitya (C. albicans) of sulfonamides 5-8 
 
Compound Growth inhibition (%) at 4 µg/mL 
5 25b 
6, 7 25 
8 50 
aTwenty-one strains of tested microorganisms were gram-negative bacteria; Escherichia coli ATCC 25922, 
Klebsiella pneumoniae ATCC 700603, Serratia marcescens ATCC 8100, Salmonella typhimurium ATCC 13311, 
Pseudomonas aeruginosa ATCC 15442, Pseudomonas stutzeri ATCC 17587, Shewanella putrefaciens ATCC 
8071, Achromobacter xylosoxidans ATCC 27061 and Plesiomonas shigelloides, gram-positive bacteria; Staphy-
lococcus aureus ATCC 29213, Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis ATCC 12228, 
Enterococcus faecalis ATCC 29212, Enterococcus faecalis ATCC 33186, Micrococcus lutens ATCC 10240, 
Corynebacterium diphtheriae NCTC 10356, Bacillus subtilis ATCC 6633, Streptococcus pyogenes and Listeria 
monocytogenes and diploid fungus; Candida albicans ATCC 90028 and Saccharomyces cerevisiae ATCC 2601. 
Ampicillin at 10 µg/mL was used as a control of antimicrobial testing system, it showed 100 % inhibition against S. 
aureus ATCC 29213, S. aureus ATCC 25923, B. subtilis ATCC 6633, P. shigelloides and S. pyogenes. 
bAt 128 µg/mL showed 50 % inhibition. 
 
 
Table 2: Antioxidative activities of  
sulfonamides 5-8 
 
Compounda SOD (%)  DPPH (%)  
5 NA NA 
6 15.7 NA 
7 NA NA 
8 6.1 NA 
a Compounds were tested at 300 µg/mL. 
IC50 of standard SOD is 0.75 µg/mL. 
NA = no activity. 
 
The sulfonamide 6, with OCH3 group 
at C-4′ displayed the highest SOD activity 
when compared to the compound 8 bearing 
Cl at C-4′. This could presumably explain 
that the stroger electron donating effect of 
OCH3 contributed asymmetric charge on 
4′-methoxybenzenesulfonyl moiety of the 
molecule (6). 
 
Cytotoxicity 
Cytotoxicity was evaluated against four 
cell lines (Table 3) using etoposide and/or 
doxorubicin as the reference drugs. Results 
showed that the cytotoxic activity was ob-
served for compounds 5, 7 and 8 toward 
MOLT-3 cell with IC50 values of 15.71, 
32.88 and 33.96 µg/mL, respectively. In-
terestingly, the sulfonamide 5 with NO2 
substituted at C-4′ position exerted the 
highest cytotoxicity when compared to 
compounds 7 and 8 with CH3 and Cl 
groups at C-4′, respectively. Both com-
pounds 7 and 8 had comparable cytotoxic 
effect, but with the IC50 values of ap-
proximately two folds higher than the 
compound 5. On the other hand, sulfona-
mide 6 bearing OCH3 group at C-4′ was 
shown to be inactive compound. However, 
all sulfonamides were inactive cytotoxics 
when tested with HuCCA-1, A549 and 
HepG2 cells. The results suggested that the 
substituents at C-4′ position of compounds 
5-8 governed their cytotoxicities. It is evi-
dent that an electron withdrawing group 
(NO2) at C-4′ exhibited the highest cyto-
toxicity, whereas electron releasing 
groups; CH3 and Cl provided the com-
pounds with lower cytotoxicity. In case of 
the stronger electron releasing group, 
OCH3 which exerted no cytotoxicity as 
noted for the sulfonamide 6.  
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Table 3: Cytotoxicity of sulfonamides 5-8 
 
IC50 (µg/mL)a,b Compound MOLT-3 HepG2 HuCCA-1 A549 
5 15.71±0.70 inactive inactive inactive 
6 inactive inactive inactive inactive 
7 32.88±1.75 inactive inactive inactive 
8 33.96±2.06 inactive inactive inactive 
Etoposide 0.021±0.002 19.00±1.73 - - 
Doxorubicin - 0.53±0.06 0.40±0.282 0.35±0.00 
a The assays were performed in triplicates, using etoposide and/or doxorubicin as  
reference drugs. 
b an IC50 > 50 µg/mL indicates inactive. 
 
 
CONCLUSION 
 4-Substituted (X) benzenesulfonamides 
of anthranilic acid (5-8) were prepared in 
high yields. Bioactivity testings revealed 
that all sulfonamides selectively exert anti-
fungal action (25-50 % inhibition) against 
C. albicans with low concentration at 
4 µg/mL. Some of the tested compounds (6 
and 8) show SOD activity, whereas 6 is 
shown to be the highest antioxidant. These 
sulfonamides, except for 6, selectively dis-
play cytotoxic effect toward MOLT-3 cells. 
The sulfonamide with electron withdrawing 
substituent (5, X = NO2) exhibited the 
highest cytotoxicity, but with no antioxi-
dant property. This study provided prelimi-
nary structure-activity relationship of the 
anthranilic sulfonamides useful for further 
in-depth investigation. 
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